Ability to Read Medication Labels Improved by Participation in a Low Vision Rehabilitation Program

Ferris F. L. , Kassoff A. , Bresnick G. H. , & Bailey I. L. (1982). New visual acuity charts for clinical research. American Journal of Ophthalmology, 94, 91–96.

Haynes R. B. (1979). Determinants of compliance: The disease and the mechanisms of treatment. In Haynes R. B. , Taylor D. W. , & Sackett D. L. (Eds.), Compliance in health care (pp. 49–62). Baltimore, MD: Johns Hopkins University Press.

Maberley D. A. L. , Hollands H. , Chuo J. , Tam G. , Konkal J. , Roesch M. , Veselinovic A. , Witzigmann M. , & Bassett K. (2006). The prevalence of low vision and blindness in Canada. Eye, 20, 341–346.

MacLaughlin E. , Raehl C. , Treadway A. , Sterling T. , Zoller D. , & Bond C. (2005). Assessing medication adherence in the elderly. Drugs & Aging, 22, 231–255.

Markowitz S. N. (2006). Principles of modern low vision rehabilitation. Canadian Journal of Ophthalmology, 41, 289–312.

Massof R. W. (2002). A model of the prevalence and incidence of low vision and blindness among adults in the U.S. Optometry and Vision Sciences, 79, 31–38.

Osterberg L. , & Blaschke T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.

Prevent Blindness America. (2007). The economic impact of vision problems: The toll of major adult eye disorders, visual impairment, and blindness on the U.S. economy. Chicago: Author. Retrieved from http://www.preventblindness.org/research/costofblindness.html

Teichman J. , & Markowitz S. N. (2008). Canadian research contributions to low vision rehabilitation. Canadian Journal of Ophthalmology, 43, 414–418.

World Health Organization. (2003). Failure to take prescribed medicine for chronic diseases is a massive, world-wide problem. Geneva: Author. Retrieved from http://www.who.int/mediacentre/news/releases/2003/pr54/en/index.html